COVID vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
University of Hong Kong, Sinopharm launch trial of Omicron-targeting vaccine
A total of 1,800 adult volunteers will be needed for the trial.
Commentary
Hong Kong: At the forefront of digitalisation and evolving international disputes
AI drug discovery, GLP-1, and the next wave of Hong Kong biotech listings
Capital repatriation isn't a retreat — it’s Hong Kong’s regulatory graduation
Hong Kong should build the Asia–Latin America investment corridor